PLASMA-LEVELS OF AMYLOID-BETA PROTEINS A-BETA-1-40 AND A-BETA-1-42(43) ARE ELEVATED IN DOWNS-SYNDROME

Citation
T. Tokuda et al., PLASMA-LEVELS OF AMYLOID-BETA PROTEINS A-BETA-1-40 AND A-BETA-1-42(43) ARE ELEVATED IN DOWNS-SYNDROME, Annals of neurology, 41(2), 1997, pp. 271-273
Citations number
17
Categorie Soggetti
Clinical Neurology",Neurosciences
Journal title
ISSN journal
03645134
Volume
41
Issue
2
Year of publication
1997
Pages
271 - 273
Database
ISI
SICI code
0364-5134(1997)41:2<271:POAPAA>2.0.ZU;2-N
Abstract
To investigate the effect of the overexpression of beta-amyloid precur sor protein (APP) on the production of two major amyloid beta protein (A beta) species, A beta 40 and A beta 42(43), we measured amounts of A beta 1-40 and A beta 1-42(43) in the plasma from 44 patients with Do wn's syndrome (DS) (age, 19-61 years) and 66 age-matched normal contro ls using enzyme-linked immunosorbent assays. Plasma concentrations of both A beta 1-40 and A beta 1-42(43) were increased about 3-fold and 2 -fold, respectively, in DS patients compared with normal controls. Esp ecially, the increases in plasma A beta 1-40 in DS patients were stati stically higher than the 1.5-fold increase one might predict based on the gene dose of APP in DS. These findings showed that both A beta 1-4 0 and A beta 1-42(43) are increased in plasma in DS patients, the form er more than the latter, suggesting that overexpression of APP and/or other genes may have different effects on the production of these two AP species in DS.